Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:36 2024-05-02 am EDT 5-day change 1st Jan Change
16.36 SEK -6.99% Intraday chart for Clinical Laserthermia Systems AB -12.79% -40.72%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory MT
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System CI
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories CI
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy CI
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System CI
Clinical Laserthermia Systems Names Interim CFO MT
Clinical Laserthermia Systems AB Announces CFO Changes CI
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Clinical Laserthermia Systems Gains Underwriting Commitments for Warrant Series Exercise MT
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators MT
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044 CI
Clinical Laserthermia Systems Prices Warrants; Stock Falls MT
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA CI
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore MT
Clinical Laserthermia Systems AB Receives Market Approval for Its TRANBERG Portfolio by HSA in Singapore and Initiates the Process of Commercialization in the Region CI
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise MT
Clinical Laserthermia Systems Receives SEK 8.1 Million Order from Clearpoint Neuro CI
Clinical Laserthermia Systems AB Announces Members of the Nomination Committee Appointments CI
Clinical Laserthermia Systems AB Announces Executive Changes CI
Clinical Laserthermia Reports First Prostate Cancer Patient Treatment Using Tranberg Therapy MT
Clinical Laserthermia Systems AB Announces First Patient was Safely Treated with CLS TRANBERG® Thermal Therapy system for laser ablation of Prostate Cancer CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Clinical Laserthermia Partners with Avanco Advanced Medical Solutions for Tranberg Sale in Portugal MT
Chart Clinical Laserthermia Systems AB
More charts
Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB
  5. Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore